Potential of Diabetes Medications in Treating Alcohol Use Disorder
Emerging research suggests that diabetes drugs targeting GLP-1 and GIP receptors may help reduce alcohol consumption and improve liver health, promising new avenues for alcohol use disorder treatment.
Recent research indicates that medications traditionally used for managing diabetes, specifically GLP-1 and GIP receptor agonists, may hold promise in addressing alcohol use disorder (AUD). A large-scale genetic analysis conducted by scientists at the National Institute on Alcohol Abuse and Alcoholism explored the influence of these hormones on alcohol consumption behaviors and liver health. By applying drug-target Mendelian randomization — a method that leverages genetic data to predict drug effects — researchers found that naturally occurring variations affecting GLP1R and GIPR genes were associated with reduced binge drinking and lower risk of heavy alcohol use. Notably, these genetic proxies for lowered BMI and appetite regulation correlated with decreased alcohol intake and preferences for healthier foods, such as vegetarian options, as well as improved liver function indicators like reduced NAFLD and ALT levels.
The findings suggest that drugs targeting GLP-1 and GIP receptors, already used for obesity and diabetes, could potentially be repurposed to treat AUD. This approach could also influence appetite and cravings, offering a dual benefit in managing both alcohol consumption and metabolic health. While the study did not directly test the effects of these medications on humans with AUD, it provides a foundational understanding that could guide future clinical trials. The potential to reduce hazardous drinking and improve liver health emphasizes the importance of exploring these hormonal pathways further.
Overall, this research highlights the innovative use of genetic data to identify new therapeutic avenues for alcohol use disorder, opening doors to more effective and targeted treatments in the future.
Source: https://medicalxpress.com/news/2025-10-diabetes-drugs-treatment-alcohol-disorder.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Assessing Hormone Therapy's Effects on Transgender Women's Athletic Performance
Explore recent research on how gender-affirming hormone therapy influences the athletic performance of transgender women, shedding light on physiological changes and performance outcomes in sports.
Supporting Housing as a Cost-Effective Solution for Homelessness and Opioid Crisis
Supporting housing for homeless individuals with opioid use disorder is a cost-effective strategy that saves lives and improves health outcomes, according to Stanford research. This approach offers a humane and economically sound solution to homelessness and the opioid crisis.
Colorado's Measles Outbreak Ends as US Cases Continue to Decline
Colorado's measles outbreak has ended, and the US is experiencing a significant decline in weekly cases, with ongoing outbreaks in several states emphasizing the importance of vaccination.
Impact of Legislative Changes Threatening Healthcare Access for Immigrants in Minnesota
Legislative disputes in Minnesota threaten to withdraw healthcare access for undocumented immigrants amid growing enrollment and community concern. Read more about the ongoing debate affecting vulnerable populations.